CJC 1295, a 30-amino acid peptide, primarily acts as an analogue of growth hormone-releasing hormone (GHRH). Its main function is to stimulate the natural production of our own growth hormone.  By elevating the levels of growth hormone in the body, which typically decline with age, this peptide can enhance protein synthesis. Potential outcomes include increased muscle development, enhanced fat metabolism, greater physical strength, improved skin ageing, and increased collagen production, improved bone density, strengthened immunity, and faster recovery from injuries & slow-wave sleep, also known as deep sleep. Ipamorelin, a growth hormone-releasing peptide (GHRP), plays a crucial role in regulating appetite and food intake. Ipamorelin aids in muscle mass development and fat reduction. When used in combination with CJC 1295, these peptides have the potential to significantly increase the body's production of growth hormone.

CJC 1295 + Ipamorelin stands as our most popular peptide combination

Prescription-Only Medication Notice:
This peptide is a Schedule 4 prescription-only treatment. Selecting this product does not guarantee access or approval. All patients must undergo a consultation with an AHPRA-registered medical practitioner, who will assess clinical suitability and determine whether this treatment is appropriate. Prescriptions are issued only when medically justified and in line with regulatory guidelines.

**All peptide therapies available through PHYX require a medical consultation and prescription. Treatment suitability is determined by an AHPRA-registered clinician.**